Coexistence of Takayasu’s Arteritis in Patients with Inflammatory Bowel Diseases

Table 3

Main clinical characteristics of seven patients with IBD and TA.

Patient	Sex	Age	Age at IBD diagnosis	Age at TA diagnosis	Interval from onset	IBD type	IBD surgeries	IBD drug therapy	TA drug therapy	Vascular procedures
1	F	23	11	14	3 y	UC	—	AZA+5-ASA	Warfarin	Repair of ascending aortic aneurysm with graft and mechanical aortic valve replacement
2	M	20	16	20	4 y	CD	Hemicolectomy	AZA	AAS+PDN+MTX
3	F	43	30	31	1 y	CD	—	IFX	AAS
4	F	64	25	31	6 y	CD	Hemicolectomy	IFX+AZA	AAS
5	F	21	21	21	4 months	UC	—	5-ASA	Csa+PDN; anti-IL-6R+MTX AAS	Repair of descending thoracic aortic aneurysm with graft.
6	M	40	22	31	9 y	CD	—	5-ASA+AZA	PDN
7	M	45	28	38	10 y	CD	Ileocecectomy	6-MP IFX+AZA	PDN+anti-IL-6R warfarin	Repair of ascending aortic aneurysm with graft and mechanical aortic valve replacement

IBD: inflammatory bowel disease; TA: Takayasu’s arteritis; UC: ulcerative colitis; CD: Crohn’s disease; AZA: azathioprine; 5-ASA: 5-aminosalicylic acid; IFX: infliximab; AAS: acetylsalicylic acid; MTX: methotrexate; antiIL6R: tocilizumab; 6-MP: 6-mercaptopurine; PDN: prednisone; Csa: cyclophosphamide.